Rabies control in Liberia: Joint efforts towards zero by 30.


Journal

Acta tropica
ISSN: 1873-6254
Titre abrégé: Acta Trop
Pays: Netherlands
ID NLM: 0370374

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 28 06 2019
revised: 24 11 2020
accepted: 25 11 2020
pubmed: 2 1 2021
medline: 13 5 2021
entrez: 1 1 2021
Statut: ppublish

Résumé

Despite declaration as a national priority disease, dog rabies remains endemic in Liberia, with surveillance systems and disease control activities still developing. The objective of these initial efforts was to establish animal rabies diagnostics, foster collaboration between all rabies control stakeholders, and develop a short-term action plan with estimated costs for rabies control and elimination in Liberia. Four rabies diagnostic tests, the direct fluorescent antibody (DFA) test, the direct immunohistochemical test (dRIT), the reverse transcriptase polymerase chain reaction (RT-PCR) assay and the rapid immunochromatographic diagnostic test (RIDT), were implemented at the Central Veterinary Laboratory (CVL) in Monrovia between July 2017 and February 2018. Seven samples (n=7) out of eight suspected animals were confirmed positive for rabies lyssavirus, and molecular analyses revealed that all isolates belonged to the Africa 2 lineage, subgroup H. During a comprehensive in-country One Health rabies stakeholder meeting in 2018, a practical workplan, a short-term action plan and an accurately costed mass dog vaccination strategy were developed. Liberia is currently at stage 1.5/5 of the Stepwise Approach towards Rabies Elimination (SARE) tool, which corresponds with countries that are scaling up local-level interventions (e.g. dog vaccination campaigns) to the national level. Overall an estimated 5.3 - 8 million USD invested over 13 years is needed to eliminate rabies in Liberia by 2030. Liberia still has a long road to become free from dog-rabies. However, the dialogue between all relevant stakeholders took place, and disease surveillance considerably improved through implementing rabies diagnosis at the CVL. The joint efforts of diverse national and international stakeholders laid important foundations to achieve the goal of zero dog-mediated human rabies deaths by 2030.

Identifiants

pubmed: 33385361
pii: S0001-706X(20)31700-9
doi: 10.1016/j.actatropica.2020.105787
pii:
doi:

Substances chimiques

DNA, Viral 0
Rabies Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105787

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Garmie Voupawoe (G)

Leon Quist Ledlum Central Veterinary Laboratory, Ministry of Agriculture, Gardnesville, Monrovia, Republic of Liberia; Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland. Electronic address: garmievoupawoe@gmail.com.

Roland Varkpeh (R)

Ministry of Agriculture, LIBSSOCO, Gardnesville, Monrovia, Republic of Liberia. Electronic address: varkpeh71@yahoo.com.

Varney Kamara (V)

Leon Quist Ledlum Central Veterinary Laboratory, Ministry of Agriculture, Gardnesville, Monrovia, Republic of Liberia. Electronic address: vascomk1982@yahoo.com.

Sonpon Sieh (S)

National Public Health Institute of Liberia (NPHIL), Congo Town, Monrovia of Liberia, Liberia. Electronic address: sblamosieh@yahoo.com.

Abdallah Traoré (A)

Laboratoire Central Vétérinaire, Km 8, Route de Koulikoro, BP 2295 Bamako, Mali. Electronic address: abdalltraor@gmail.com.

Cristian De Battisti (C)

Food and Agriculture Organisation of United Nations, Animal Health Services (AGAH), Viale delle Terme di Caracalla, 00153 Rome, Italy. Electronic address: cristian.debattisti@fao.org.

Angélique Angot (A)

Food and Agriculture Organisation of United Nations, Animal Health Services (AGAH), Viale delle Terme di Caracalla, 00153 Rome, Italy. Electronic address: Angelique.Angot@fao.org.

Luis Filipe L de J Loureiro (LFLJ)

Universidade Lusofona Medicina Veterinaria, Campo Grande, 376, 1749-024 Lisboa, Portugal. Electronic address: Lloureir@tulane.edu.

Baba Soumaré (B)

Food and Agriculture Organization of the United Nations (FAO-UN), Emergency Center for Transboundary Animal Diseases (ECTAD), Accra, Ghana. Electronic address: baba.soumare@fao.org.

Gwenaëlle Dauphin (G)

Ceva Santé Animale, Av. de la Ballastière, 33450 Libourne, France. Electronic address: gwenaelle.dauphin@ceva.com.

Wolde Abebe (W)

Food and Agriculture Organization of the United Nations (FAO-UN), Emergency Center for Transboundary Animal Diseases (ECTAD), Monrovia, Liberia. Electronic address: abebe.wolde@fao.org.

André Coetzer (A)

Department of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Lynnwood Rd, Hatfield, Pretoria 0002, South Africa; Global Alliance for Rabies Control SA NPC, Erasmus Forum A434, South Erasmus Rand, 0181 Pretoria, South Africa. Electronic address: andre.coetzer@rabiesalliance.org.

Terence Scott (T)

Department of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Lynnwood Rd, Hatfield, Pretoria 0002, South Africa; Global Alliance for Rabies Control SA NPC, Erasmus Forum A434, South Erasmus Rand, 0181 Pretoria, South Africa. Electronic address: terence.scott@rabiesalliance.org.

Louis Nel (L)

Department of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Lynnwood Rd, Hatfield, Pretoria 0002, South Africa; Global Alliance for Rabies Control USA, 529 Humboldt St., Suite 1, Manhattan, Kansas, 66502, USA. Electronic address: louis.nel@rabiesalliance.org.

Jesse Blanton (J)

Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging & Zoonotic Infectious Diseases, CDC, 1600 Clifton Rd, Atlanta, Georgia, 30329, USA. Electronic address: asi5@cdc.gov.

Laurent Dacheux (L)

Institut Pasteur, Unit Lyssavirus Epidemiology and Neuropathology, National Reference Center for Rabies and WHO Collaborating center for Reference and Research on Rabies, 28 rue du Docteur Roux, 75724 Paris Cedex 15, France. Electronic address: laurent.dacheux@pasteur.fr.

Simon Bonas (S)

Institut Pasteur, Unit Lyssavirus Epidemiology and Neuropathology, National Reference Center for Rabies and WHO Collaborating center for Reference and Research on Rabies, 28 rue du Docteur Roux, 75724 Paris Cedex 15, France. Electronic address: simon.bonas@pasteur.fr.

Hervé Bourhy (H)

Institut Pasteur, Unit Lyssavirus Epidemiology and Neuropathology, National Reference Center for Rabies and WHO Collaborating center for Reference and Research on Rabies, 28 rue du Docteur Roux, 75724 Paris Cedex 15, France. Electronic address: herve.bourhy@pasteur.fr.

Morgane Gourlaouen (M)

FAO Reference Centre for Rabies, Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10, 35020 Legnaro (PD), Italy. Electronic address: mgourlaouen@izsvenezie.it.

Stefania Leopardi (S)

FAO Reference Centre for Rabies, Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10, 35020 Legnaro (PD), Italy. Electronic address: sleopardi@izsvenezie.it.

Paola De Benedictis (P)

FAO Reference Centre for Rabies, Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10, 35020 Legnaro (PD), Italy. Electronic address: pdebenedictis@izsvenezie.it.

Monique Léchenne (M)

Environment and Sustainability Institute, University of Exeter, Penryn Campus, UK. Electronic address: M.S.Lechenne@exeter.ac.uk.

Jakob Zinsstag (J)

Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland. Electronic address: jakob.zinsstag@swisstph.ch.

Stephanie Mauti (S)

Institut Pasteur, Unit Lyssavirus Epidemiology and Neuropathology, National Reference Center for Rabies and WHO Collaborating center for Reference and Research on Rabies, 28 rue du Docteur Roux, 75724 Paris Cedex 15, France; Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland. Electronic address: stephanie.mauti@swisstph.ch.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH